Replies to post #407137 on Elite Pharmaceuticals Inc (ELTP)

[Winechemist]

Correction, Nasrat stated that the FDA appears to have finished the review of their application, and they stated that they needed 30 days additional, from whenever they communicated last with Elite to finish review of the DMF for the API holder. Based on my interpretation is that if there are no issues with the DMF then approval should proceed, once again from my perspective based on my experiences with how the FDA communicates. Either way its good news I feel as Nasrat already appears to have bought everything so I think he knows the outcome. Cheers